An interventional study of Brachiobasilic arteriovenous fistula followed by basilic vein superficialization. and Brachiobasilic arteriovenous fistula in Venous Hypertension, Side-to-Side and End-to-Side, sponsored by Ain Shams University. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-16.
Sponsored by Ain Shams University · Not applicable, Interventional, and Treatment
The study aimed to compare the incidence of postoperative venous hypertension between side-to-side (STS) and end-to-side (ETS) brachiobasilic arteriovenous fistulae.
Arteriovenous fistula (AVF) is the gold standard for vascular access for hemodialysis (HD) with an overall success rate of about 84.0%, designed to improve the effectiveness of dialysis.
Brachiobasilic arteriovenous fistula (BBAVF) creation may involve either an end-to-side (ETS) or a side-to-side (STS) anastomotic configuration. The STS technique preserves the distal venous segment and may provide additional usable veins for cannulation. However, continued arterialized flow into the distal venous limb may increase forearm venous pressure, thereby predisposing patients to venous hypertension. In contrast, ETS anastomosis directs blood flow primarily toward the proximal venous outflow, thereby reducing distal venous congestion.
Ain Shams University is the lead sponsor of 1,932 studies on the registry; 433 are open to participants now.
Of its 33 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients who underwent creation of a brachiobasilic arteriovenous fistula followed by basilic vein superficialization.
Procedure: Brachiobasilic arteriovenous fistula followed by basilic vein superficialization.
Patients who underwent creation of a brachiobasilic arteriovenous fistula.
Procedure: Brachiobasilic arteriovenous fistula
Patients who underwent creation of a brachiobasilic arteriovenous fistula followed by basilic vein superficialization.
Patients who underwent creation of a brachiobasilic arteriovenous fistula.
Incidence of postoperative venous hypertension
Percentage of participants who develop postoperative venous hypertension in the operated upper limb following brachiobasilic arteriovenous fistula creation was recorded.
Time frame: 6 months after surgery
Plan to share: Yes — The data will be available upon a reasonable request from the corresponding author after the end of study for one year.
Supporting information: Study protocol
Time frame: After the end of study for one year.
Access criteria: The data will be available upon a reasonable request from the corresponding author.
No publications or documents are linked to this record.
Ran from Jul 2021 to primary completion in Jul 2024, 36 months.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.